Plasma infliximab monitoring contributes to optimize Takayasu arteritis treatment: a case report

BACKGROUND: Infliximab (IFX), a mouse-human chimeric monoclonal antibody against human tumor necrosis factor alpha, is used in refractory cases of Takayasu arteritis. Several factors influence the pharmacokinetics of therapeutic antibodies including IFX. Monitoring plasma levels of IFX could be a us...

Descripción completa

Detalles Bibliográficos
Autores principales: Masui, Sho, Yonezawa, Atsushi, Izawa, Kazushi, Hayakari, Makoto, Asakura, Kayoko, Taniguchi, Risa, Isa, Masahiko, Shibata, Hirofumi, Yasumi, Takahiro, Nishikomori, Ryuta, Takita, Junko, Matsubara, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498684/
https://www.ncbi.nlm.nih.gov/pubmed/31073411
http://dx.doi.org/10.1186/s40780-019-0136-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498684/
https://www.ncbi.nlm.nih.gov/pubmed/31073411
http://dx.doi.org/10.1186/s40780-019-0136-4

Ejemplares similares